1. The revival of CpG oligonucleotide-based cancer immunotherapies;Adamus;Contemp. Oncol. (Pozn.),2018
2. Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo;Alcazar;Int. J. Cancer,2012
3. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma;Andtbacka;J. Clin. Oncol.,2015
4. Patterns of clinical response with talimogene laherparepvec (T-VEC) in patients with melanoma treated in the OPTiM phase III clinical trial;Andtbacka;Ann. Surg. Oncol.,2016
5. Incyte and Merck Provide Update on Phase 3 Study of Epacadostat in Combination With KEYTRUDA® (pembrolizumab) in Patients with Unresectable or Metastatic Melanoma [press release];Anon,2018